Startup Details

Somer Baburek

CEO

Hera Biotech

Company Name

Hera Biotech

Company Website

http://www.herabiotech.com

Industry

Biotechnology

Location

UNITED STATES

Developmental Stage

*********

Approx Revenue for current Year

*********

Type of funding

*********

Pre-money Valuation (USD)

*********

Type of offering

*********

Amount of Capital seeking in current round (USD)

*********

Previous capital raised (USD)

*********

Monthly Burn rate (USD)

*********

Company Description

Currently, there are between 7-13M women in the US with endometriosis (endo) and, according to the CDC, each year at least 3M women schedule a doctor appointment complaining of menstrual issues, a common symptom of endo. The current method of diagnosis is a surgery which must be done in an operating room (OR), under general anesthesia and relies on... Read more

Product/Service Description

Unlike the surgical method, Hera’s test (MetriDxTM) is capable of diagnosing and staging endo, quantitatively. This capability provides physicians objective data, which can be used in clinical management of the disease. Collecting patient tissue samples is a common practice in physician offices. The uterine tissue sample required for Hera’s test wi... Read more

Management Team

Somer Baburek

CEO

Paul Castella

Chairman of the Board

Bruce Nicholson

CSO

Nameer Kirma

Chair, Scientific Advisory

Advisor Team

Previous Investors

Maria Maso

Director

Justin McKenzie

Director

Brittany Barretto

GP

Company Information

Date Company Founded
02/14/2020
Registered Location
Delaware
Legal Name
Hera Biotech Inc
Date Company Registered
02/17/2020
Address
, San Antonio, Texas
Country